1. Management of IgA nephropathy: Evidence-based recommendations
Linda Nolin, Maryse Courteau 
Kidney International 
Volume 55, Pages S56-S62 (June 1999)
DOI: /j x
Copyright © 1999 International Society of Nephrology Terms and Conditions

2. Fig. 1
Decision tree for biopsy-proven IgA nephropathy (IgAN). Blood pressure in all cases should be controlled with angiotensin converting enzyme inhibitors (ACEI).
Kidney International  , S56-S62DOI: ( /j x)
Copyright © 1999 International Society of Nephrology Terms and Conditions

3. Fig. 2
Decision tree for biopsy-proven IgA nephropathy (IgAN) with a rapidly progressive course.
Kidney International  , S56-S62DOI: ( /j x)
Copyright © 1999 International Society of Nephrology Terms and Conditions

4. Fig. 3
Decision tree for IgA proven nephropathy with macroscopic hematuria.
Kidney International  , S56-S62DOI: ( /j x)
Copyright © 1999 International Society of Nephrology Terms and Conditions